DIFFERENCES IN CARDIAC CALCIUM RELEASE CHANNEL (RYANODINE RECEPTOR) EXPRESSION IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE CAUSED BY ISCHEMIC VERSUS DILATED CARDIOMYOPATHY

被引:170
|
作者
BRILLANTES, AM
ALLEN, P
TAKAHASHI, T
IZUMO, S
MARKS, AR
机构
[1] CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,DIV MOLEC MED,BOX 1126,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT MED,DIV CARDIOL,NEW YORK,NY 10029
[3] BRIGHAM & WOMENS HOSP,DEPT ANESTHESIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,MOLEC MED UNIT,BOSTON,MA 02215
[5] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV CARDIOVASC,BOSTON,MA 02215
关键词
IDIOPATHIC DILATED CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; CALCIUM RELEASE CHANNEL; MESSENGER RNA; RYANODINE RECEPTOR;
D O I
10.1161/01.RES.71.1.18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular basis for the systolic and diastolic dysfunction characteristic of end-stage heart failure in humans remains poorly understood. It has been proposed that both abnormal calcium handling and defects in the contractile apparatus may contribute to the myocardial dysfunction. Two channels, the calcium release channel (CRC) or ryanodine receptor of the sarcoplasmic reticulum (SR), and the slow calcium channel or dihydropyridine receptor (DHPR) of the transverse tubule, play key roles in regulating intracellular calcium concentration and in excitation-contraction (E-C) coupling in the heart. The DHPR serves as the voltage sensor and plasma membrane calcium channel resulting in activation of the CRC during E-C coupling in heart muscle. In this study, we investigated the levels of CRC expression in several forms of end-stage heart failure in humans. A cardiac CRC cDNA was cloned from rabbit and used as a probe for Northern blot analyses to determine mRNA levels in the left ventricles of normal (n=4) and cardiomyopathic (n=34) human hearts from patients undergoing cardiac transplantation. Compared with normal patients, patients with ischemic cardiomyopathy (n=18) showed a 28% decrease in CRC mRNA levels (p<0.025) and patients with idiopathic dilated cardiomyopathy (n=14) a nonsignificant 12% increase. In these same hearts, alpha-actin levels were unchanged in end-stage heart failure, as has been previously reported. This is the first report indicating that the expression of the CRC mRNA is abnormal in end-stage human heart failure. The decreased expression of the CRC found specifically in patients with ischemic myopathy (but not idiopathic dilated cardiomyopathy) may, in part, explain differences in calcium handling and response to therapy observed among patients with different forms of cardiomyopathy. Decreased CRC expression could be related to abnormal contractile function in cardiomyopathic muscle resulting from ischemic insult.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [31] Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
    Thomas, CV
    Coker, ML
    Zellner, JL
    Handy, JR
    Crumbley, AJ
    Spinale, FG
    CIRCULATION, 1998, 97 (17) : 1708 - 1715
  • [32] DIFFERENTIAL REGULATION OF 2 TYPES OF INTRACELLULAR CALCIUM-RELEASE CHANNELS DURING END-STAGE HEART-FAILURE
    GO, LO
    MOSCHELLA, MC
    WATRAS, J
    HANDA, KK
    FYFE, BS
    MARKS, AR
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02): : 888 - 894
  • [33] Phosphodiesterase 4D associates with the cardiac calcium release channel (Ryanodine receptor) and protects from hypertrophy and heart failure
    Lehnart, SE
    Wehrens, XH
    Reiken, SR
    Jin, SIC
    Vest, JA
    Marks, AR
    CIRCULATION, 2004, 110 (17) : 227 - 228
  • [34] Tranilast, Transient Receptor Potential Vanilloid 2 Antagonist, Ameliorates End-Stage Heart Failure of Mice With Dilated Cardiomyopathy
    Iwata, Yuko
    Komamura, Kazuo
    CIRCULATION, 2014, 130
  • [35] Altered expression of cardiac PP2A in patients with end-stage heart failure
    Krause, T
    Aleth, S
    Balzer, F
    Schmitz, W
    Neumann, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R96 - R96
  • [36] Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy
    Andréoletti, L
    Bourlet, T
    Moukassa, D
    Rey, L
    Hot, D
    Li, YW
    Lambert, V
    Gosselin, B
    Mosnier, JF
    Stankowiak, C
    Wattré, P
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1222 - 1227
  • [37] Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure
    Szperl, M.
    Roszczynko, M.
    Leszek, P.
    Kolsut, P.
    Paczkowska, A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 812 - 812
  • [38] Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure
    Szperl, M.
    Roszczynko, M.
    Paczkowska, A.
    Leszek, P.
    Kolsut, P.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 938 - 938
  • [39] The cardiac epigenome encodes racial and socioeconomic differences among patients with end-stage heart failure
    Pepin, M.
    Ha, C. M.
    Potter, L. A.
    Bakshi, S.
    Barchue, J.
    Pogwizd, S. M.
    Pamboukian, S. V.
    Hidalgo, B.
    Wende, A. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 60 - 60
  • [40] DIFFERENTIAL INOTROPIC EFFECTS OF FLOSEQUINAN IN VENTRICULAR MUSCLE FROM NORMAL FERRETS VERSUS PATIENTS WITH END-STAGE HEART-FAILURE
    PERREAULT, CL
    HAGUE, NL
    LOH, E
    HUNNEYBALL, IM
    SIM, MF
    MORGAN, JP
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (03) : 511 - 516